|
|
 | | | |
- close
- close
- close
- close
Cpex Pharmaceuticals (CPEX) |
StreetInsider.com
Apr 5
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/CPEX+Pharmaceuticals+%28CPEX%29+Completes+Sale+to+FCB+I+Holdings%3B+Shares+to+Cease+Trading+on+NASDAQ/6412117.html for the full story.
Benzinga
Mar 24
Comment
CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) today announced that, based on the vote count certified by the independent inspector of election, IVS Associates, Inc., stockholders have approved the Company's proposed merger agreement with FCB I...
StreetInsider.com
Mar 23
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/CPEX+Pharma+%28CPEX%29+Issues+Facts+About+FCB+I+Holdings+Transaction/6383732.html for the full story.
Benzinga
Mar 22
Comment
Mangrove Partners, owners of 149,373 shares representing approximately 5.71% of the outstanding shares of CPEX Pharmaceuticals, Inc. (Nasdaq: CPEX), questions CPEX's apparent desperate plea to stockholders asking them to support a merger that will...
Benzinga
Mar 18
Comment
CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) today announced that its Board of Directors has completed its review of the unsolicited, non-binding letter received from Mangrove Partners on March 16, 2011 revising the terms of the potential alternative...
Benzinga
Mar 17
Comment
CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) today confirmed that it has received an unsolicited, non-binding letter from Mangrove Partners revising the terms of the potential alternative transaction involving a recapitalization of CPEX that Mangrove...
Benzinga
Mar 2
Comment
CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) today issued a letter to its stockholders regarding its proposal to approve the merger agreement with FCB I Holdings Inc., under which CPEX stockholders will receive $27.25 per share in cash, and...
TheStreet.com
Jan 21
Comment
NEW YORK (TheStreet) -TheStreet Ratings' stock model upgraded Education Management Corp to 'Hold' from 'Sell'. Net income at this $2.3 billion market cap, post-secondary education company jumped 131.2% to a profit of $36.5 million in the fiscal...
FierceBiotech
Jan 4
Comment
A unit of Footstar Corp., a holding company, has agreed to acquire CPEX Pharmaceuticals for $76.6 million in cash. The bid is worth $27.25 a share, more than twice what it was a year ago as back-to-back quarterly profits helped fuel investor...
MarketWatch
Jan 4
Comment
MarketWatch’s daily rundown of major gainers and decliners in the U.S. stock market.
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
